|
Name of Depositor
|
AG Karlson, Trudeau Mycobacterial Culture Collection - TMC
|
|
Isolation
|
Derived from existing strain New York, United States Isolation date: 1934
|
|
References
|
Maruyama C. Immunotherapeutic agent for tumors comprising lipopolysaccharide as an active component. US Patent 4,394,502 dated Jul 19 1983
. . J. Exp. Med. 60: 515-540, 1934.
Runyon EH, et al. Mycobacterium tuberculosis, M. bovis and M. microti species descriptions. Zentralbl. Bakteriol., I Abt., Orig. 204: 405-413, 1967.
Klemens SP, et al. Therapy of multidrug-resistant tuberculosis: lessons from studies with mice. Antimicrob. Agents Chemother. 37: 2344-2347, 1993. PubMed: 8285617
Newton GL, et al. Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J. Bacteriol. 178: 1990-1995, 1996. PubMed: 8606174
Li Z, et al. Rapid detection of Mycobacterium avium in stool samples from AIDS patients by immunomagnetic PCR. J. Clin. Microbiol. 34: 1903-1907, 1996. PubMed: 8818878
Hackbarth CJ, et al. Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 41: 1182-1185, 1997. PubMed: 9145897
derived from E.R. Baldwin's human-lung isolate H37 by W. Steenken
|
|
Cross References
|
Nucleotide (GenBank) :
BX842578
Mycobacterium tuberculosis H37Rv complete genome; segment 7/13.
Nucleotide (GenBank) :
U06258
Mycobacterium tuberculosis ATCC 25618 catalase (katG) gene, complete cds.
Nucleotide (GenBank) :
AL123456
Mycobacterium tuberculosis H37Rv complete genome.
|